TENAX THERAPEUTICS, INC. Deferred Revenue
TENAX THERAPEUTICS, INC. (TENX) had Deferred Revenue of $0 as of 2015-04-30, per its 10-K filed 2015-07-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2016-03-14
- 2015-04-30: Deferred Revenue $0.00.
- 2015-01-31: Deferred Revenue $129.94K.
- 2014-10-31: Deferred Revenue $129.94K.
- 2014-07-31: Deferred Revenue $129.94K.
| Period end | Deferred Revenue |
|---|---|
| 2015-04-30 | $0.00 10-K · filed 2015-07-14 |
| 2015-01-31 | $129.94K 10-Q · filed 2015-03-17 |
| 2014-10-31 | $129.94K 10-Q · filed 2014-12-15 |
| 2014-07-31 | $129.94K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $124.52K 10-KT · filed 2016-03-14 |
| 2014-01-31 | $123.79K 10-Q · filed 2014-03-17 |
| 2013-10-31 | $52.28K 10-Q · filed 2013-12-17 |
| 2013-07-31 | $50.94K 10-Q · filed 2013-09-17 |
| 2013-04-30 | $185.07K 10-K · filed 2014-07-29 |
| 2013-01-31 | $209.83K 10-Q · filed 2013-03-18 |
| 2012-10-31 | $229.47K 10-Q · filed 2012-12-14 |
| 2012-07-31 | $235.26K 10-Q · filed 2012-09-19 |
| 2012-04-30 | $244.01K 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |